12.97

4.00% -0.54

After Hours: 13.00 0.03 +0.23%

Lenz Therapeutics Inc (LENZ)

Overview News Price History Discussions Forecast

Lenz Therapeutics Inc stock is traded at $12.97, with a volume of 527.90K. It is down -4.00% in the last 24 hours and down -16.70% over the past month. LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Previous Close:

$13.51

Open:

$13.44

24h Volume:

527.90K

Relative Volume:

0.48

Market Cap:

$405.83M

Revenue:

Net Income/Loss:

$-69.47M

P/E Ratio:

-2.3172

EPS:

-5.5973

Net Cash Flow:

$-73.92M

1W Performance:

-7.16%

1M Performance:

-16.70%

6M Performance:

-64.30%

1Y Performance:

-47.79%

1-Day Range:

$12.86

$13.54

1-Week Range:

$12.76

$15.04

52-Week Range:

$12.76

$50.40

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name

Lenz Therapeutics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

858-925-7000

Address

201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH

Employee

Twitter

Next Earnings Date

Latest SEC Filings

LENZ's Discussions on Twitter

Compare LENZ vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LENZ Lenz Therapeutics Inc	12.97	422.73M	0	-69.47M	-73.92M	-5.5973
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-25	Resumed	Piper Sandler	Overweight
Mar-18-25	Initiated	TD Cowen	Buy
Sep-27-24	Initiated	Raymond James	Outperform
Aug-12-24	Initiated	H.C. Wainwright	Buy
Apr-15-24	Initiated	Leerink Partners	Outperform
Apr-15-24	Initiated	William Blair	Outperform
Apr-10-24	Initiated	Citigroup	Buy
Mar-27-24	Initiated	Piper Sandler	Overweight
Feb-23-23	Downgrade	BofA Securities	Neutral → Underperform
Feb-23-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-23-23	Downgrade	Cowen	Outperform → Market Perform
Jan-25-23	Downgrade	BTIG Research	Buy → Neutral
Jan-18-23	Downgrade	BofA Securities	Buy → Neutral
Jan-06-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jan-06-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
Sep-15-22	Initiated	Cantor Fitzgerald	Overweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Apr-14-22	Initiated	BTIG Research	Buy
Mar-22-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-18-22	Initiated	RBC Capital Mkts	Sector Perform
Jul-20-21	Initiated	Morgan Stanley	Overweight
Jul-20-21	Initiated	SVB Leerink	Outperform

View All

Lenz Therapeutics Inc Stock (LENZ) Latest News

Feb 09, 2026

Is LENZ Therapeutics Inc. benefiting from interest rate changesWeekly Trading Summary & Low Risk High Win Rate Picks - mfd.ru

Feb 09, 2026

Feb 08, 2026

Guidance Update: Can LENZ Therapeutics Inc be the next market leaderEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn

Feb 08, 2026

Feb 06, 2026

No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN

Feb 06, 2026

Feb 05, 2026

Investment Recap: Why is LENZ Therapeutics Inc stock going upQuarterly Profit Review & Growth Focused Entry Point Reports - baoquankhu1.vn

Feb 05, 2026

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Feb 05, 2026

Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail

Feb 05, 2026

Aug Outlook: What are LENZ Therapeutics Incs recent SEC filings showingTrade Risk Summary & Technical Pattern Recognition Alerts - baoquankhu1.vn

Feb 05, 2026

Feb 04, 2026

Lenz Therapeutics price target lowered to $35 from $52 at BofA - TipRanks

Feb 04, 2026

LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp By Investing.com - Investing.com South Africa

Feb 04, 2026

LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp - Investing.com

Feb 04, 2026

Jan 30, 2026

Why Is LENZ Therapeutics Stock Trading Lower Today?LENZ Therapeutics (NASDAQ:LENZ) - Benzinga

Jan 30, 2026

Jan 29, 2026

What is the cash position of LENZ Therapeutics Inc.July 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru

Jan 29, 2026

Is LENZ Therapeutics Inc. stock a buy or sell2025 Biggest Moves & Precise Buy Zone Tips - mfd.ru

Jan 29, 2026

Jan 28, 2026

Bull Run: Will LENZ Therapeutics Inc outperform its industry peersJuly 2025 Retail & High Win Rate Trade Tips - baoquankhu1.vn

Jan 28, 2026

Jan 27, 2026

LENZ Therapeutics and Sarah Jessica Parker Launch ‘Make it VIZZable’ Campaign - VisionMonday.com

Jan 27, 2026

Jan 26, 2026

In first celebrity partnership, Lenz Therapeutics taps Sarah Jessica Parker for vision campaign - Medical Marketing and Media

Jan 26, 2026

Insider Trends: Is Okeanis Eco Tankers Corp a defensive stockEarnings Growth Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn

Jan 26, 2026

Sovran Advisors LLC Has $4.98 Million Stock Holdings in LENZ Therapeutics, Inc. $LENZ - MarketBeat

Jan 26, 2026

Aug PostEarnings: Why is LENZ Therapeutics Inc stock going up2025 Support & Resistance & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Jan 26, 2026

Nasdaq Moves: Why is LENZ Therapeutics Inc stock going upRate Hike & Daily Market Momentum Tracking - baoquankhu1.vn

Jan 26, 2026

Jan 24, 2026

Trading Action: Is LENZ Therapeutics Inc stock a buy or sellPortfolio Value Summary & Real-Time Volume Spike Alerts - baoquankhu1.vn

Jan 24, 2026

Jan 23, 2026